Severe generalized dystonia due to primary putaminal degeneration: Case report and review of the literature

Movement Disorders

Volumn 17, Issue 3, 2002, Pages 576-584

  Walker, Ruth H ^a,b   Purohit, Dushyant P ^b   Good, Paul F ^b   Perl, Daniel P ^b   Brin, Mitchell F ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Dystonia; Neurodegeneration; Putamen

Indexed keywords

BACLOFEN; BOTULINUM TOXIN; CARBAMAZEPINE; CARBIDOPA PLUS LEVODOPA; CLONIDINE; DIAZEPAM; TRIHEXYPHENIDYL; TYROSINE 3 MONOOXYGENASE;

ADULT; ARTICLE; BRAIN DEGENERATION; BRAIN NERVE CELL; BRAIN SPONGIOSIS; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DISEASE SEVERITY; DYSTONIA; GLIOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROCEPHALY; MALE; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUTAMEN; SUBSTANTIA NIGRA; THALAMOTOMY;

ADULT; DYSTONIC DISORDERS; FATAL OUTCOME; HUMANS; MALE; NEURODEGENERATIVE DISEASES; PUTAMEN;

EID: 0036589840     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10098     Document Type: Article

References (92)

1. Fahn S, Bressman SB, Marsden CD. Classification of dystonia. Adv Neurol 1998;78:1-10.
2. Mark MH, Sage JI, Dickson DW, Heikkila RE, Manzino L, Schwarz KO, Duvoisin RC. Meige syndrome in the spectrum of Lewy body disease. Neurology 1994;44:1432-1436.
3. Zweig RM, Hedreen JC. Brain stem pathology in cranial dystonia. Adv Neurol 1988;49:395-407.
4. Zweig RM, Hedreen JC, Jankel WR, Casanova MF, Whitehouse PJ, Price DL. Pathology in brainstem regions of individuals with primary dystonia. Neurology 1988;38:702-706.
5. Gibb WR, Lees AJ, Marsden CD. Pathological report of four patients presenting with cranial dystonias. Mov Disord 1988;3:211-221.
6. Kulisevsky J, Marti MJ, Ferrer I, Tolosa E. Meige syndrome: neuropathology of a case. Mov Disord 1988;3:170-175.
7. Gibb WR, Kilford L, Marsden CD. Severe generalised dystonia associated with a mosaic pattern of striatal gliosis. Mov Disord 1992;7:217-223.
8. Tarlov E. On the problem of the pathology of spasmodic torticollis in man. J Neurol Neurosurg Psychiatry 1970;33:457-463.
9. Zeman W. Pathology of the torsion dystonias (dystonia musculorum deformans). Neurology 1970;20:79-88.
10. Garcia-Albea E, Franch O, Munoz D, Ricoy JR. Brueghel's syndrome, report of a case with postmortem studies. J Neurol Neurosurg Psychiatry 1981;44:437-440.
11. Bhatia KP, Marsden CD. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 1994;117:859-876.
12. Marsden CD, Obeso JA, Zarranz JJ, Lang AE. The anatomical basis of symptomatic hemidystonia. Brain 1985;108:463-483.
13. Grimes JD, Hassan MN, Quarrington AM, D'Alton J. Delayed-onset posthemiplegic dystonia: CT demonstration of basal ganglia pathology. Neurology 1982;32:1033-1035.
14. Demierre B, Rondot P. Dystonia caused by putamino-capsulocaudate vascular lesions. J Neurol Neurosurg Psychiatry 1983;46: 404-409.
15. Lehericy S, Vidailhet M, Dormont D, Pierot L, Chiras J, Mazetti P, Marsault C, Agid Y. Striatopallidal and thalamic dystonia. a magnetic resonance imaging anatomoclinical study. Arch Neurol 1996; 53:241-250.
16. Pettigrew LC, Jankovic J. Hemidystonia: a report of 22 patients and a review of the literature. J Neurol Neurosurg Psychiatry 1985; 48:650-657.
17. Giroud M, Lemesle M, Madinier G, Billiar T, Dumas R. Unilateral lenticular infarcts: radiological and clinical syndromes, aetiology, and prognosis. J Neurol Neurosurg Psychiatry 1997;63:611-615.
18. Krauss JK, Kiriyanthan GD, Borremans JJ. Cerebral arteriovenous malformations and movement disorders. Clin Neurol Neurosurg 1999;101:92-99.
19. Hori A, Hirose G, Kataoka S, Tsukada K, Tonami H. Delayed postanoxic encephalopathy after strangulation-the serial neuroradiological and neurochemical studies. Rinsho Shinkeigaku 1990; 30:731-737.
20. Williams FJ, Walshe JM. Wilson's disease. An analysis of the cranial computerized tomographic appearances found in 60 patients and the changes in response to treatment with chelating agents. Brain 1981;104:735-752.
21. Magalhaes ACA, Caramelli P, Menezes JR, Lo LS, Bacheschi LA, Barbosa ER, Rosemberg LA, Magalhaes A. Wilsons disease-MRI with clinical correlation. Neuroradiology 1994;36:97-100.
22. Starosta-Rubinstein S, Young AB, Kluin K, Hill G, Aisen AM, Gabrielsen T, Brewer GJ. Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging. Arch Neurol 1987;44:365-370.
23. Critchley EM, Clark DB, Wikler A. Acanthocytosis and neurological disorder without betalipoproteinemia. Arch Neurol 1968;18: 134-140.
24. Bird TD, Cederbaum S, Valpey RW, Stahl WL. Familial degeneration of the basal ganglia with acanthocytosis: a clinical, neuropathological, and neurochemical study. Ann Neurol 1978;3:253-258.
25. Vance JM, Pericak Vance MA, Bowman MH, Payne CS, Fredane L, Siddique T, Roses AD, Massey EW. Chorea-acanthocytosis: a report of three new families and implications for genetic counselling. Am J Med Genet 1987;28:403-410.
26. Kito S, Itoga E, Hiroshige Y, Matsumoto N, Miwa S. A pedigree of amyotrophic chorea with acanthocytosis. Arch Neurol 1980;37: 514-517.
27. Levine IM, Estes JW, Looney JM. Hereditary neurological disease with acanthocytosis. A new syndrome. Arch Neurol 1968;19:403-409.
28. Yamamoto T, Hirose G, Shimazaki K, Takado S, Kosoegawa H, Saeki M. Movement disorders of familial neuroacanthocytosis syndrome. Arch Neurol 1982;39:298-301.
29. Hall K, Gardner-Medwin D. CT scan appearances in Leigh's disease (subacute necrotizing encephalomyelopathy). Neuroradiology 1978;16:48-50.
30. Cheek JC, Riggs JE, Lilly RL. Extensive brain calcification and progressive dysarthria and dysphagia associated with chronic hypoparathyroidism. Arch Neurol 1990;47:1038-1039.
31. Derex L, Broussolle E, Martins A, Schiola C, Chazot G. Striatopallido-dentate calcifications and acquired facial atrophy. [Calcifications striato-pallido-dentelees et atrophie faciale acquise.]. Rev Neurol (Paris) 1995;151:559-562.
32. Callender JS. Non-progressive familial idiopathic intracranial calcification: a family report. J Neurol Neurosurg Psychiatry 1995; 59:432-434.
33. Burton K, Farrell L, Li D, Calne DB. Lesions of the putamen and dystonia: CT and magnetic resonance imaging. Neurology 1984; 34:962-965.
34. Bhaumik S, Behari M, Ahuja GK. Bilateral basal ganglia lucencies following acute febrile illness. Indian J Pediatr 1996;63:557-560.
35. Kawano H, Takeuchi Y, Misawa A, Sawada T, Imahori Y. Putaminal necrosis presenting with hemidystonia. Pediatr Neurol 2000; 22:222-224.
36. Rothfeld JM. Generalized dystonia and obsessive-compulsive disorder associated with bilateral circumscribed magnetic resonance signal changes in the putamen. J Nerv Ment Dis 1995;183:113-114.
37. Midgard R, Aarli JA, Julsrud OJ, Odegaard H. Symptomatic hemidystonia of delayed onset. Magnetic resonance demonstration of pathology in the putamen and the caudate nucleus. Acta Neurol Scand 1989;79:27-31.
38. Factor SA, Barron KD. Mosaic pattern of gliosis in the neostriatum of a North American man with craniocervical dystonia and parkinsonism. Mov Disord 1997;12:783-789.
39. Hayes MW, Ouvrier RA, Evans W, Somerville E, Morris JG. X-linked dystonia-deafness syndrome. Mov Disord 1998;13:303-308.
40. Altrocchi PM, Forno LM. Spontaneous oral-facial dyskinesia: neuropathology of a case. Neurology 1983;33:802-805.
41. Waters CH, Faust PL, Powers J, Vinters H, Moskowitz C, Nygaard T, Hunt AL, Fahn S. Neuropathology of Lubag (X-linked dystonia parkinsonism). Mov Disord 1993;8:387-390.
42. Walker RH, Danisi FO, Swope DM, Goodman RR, Germano IM, Brin MF. Intrathecal baclofen for dystonia: Benefits and complications during six years experience. Mov Disord 2000;15:1242-1247.
43. Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 1985;35:73-77.
44. Shashidharan P, Kramer BC, Walker RH, Olanow CW, Brin MF. Immunohistochemical localization and distribution of torsinA in normal human and rat brain. Brain Res 2000;853:197-206.
45. West MJ, Slomianka L, Gundersen HJ. Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. Anat Rec 1991; 231:482-497.
46. Perl DP, Good PF, Bussiere T, Morrison JH, Erwin JM, Hof PR. Practical approaches to stereology in the setting of aging- and disease-related brain banks. J Chem Neuroanat 2000;20:7-19.
47. Walker RH, Brin MF, Sandu D, Good PF, Shashidharan P. TorsinA immunoreactivity in brains of patients with DYT1 and non-DYT1 dystonia. Neurology (in press).
48. Hirsch EC, Graybiel AM, Agid YA. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 1988;334:345-348.
49. Hornykiewicz O, Kish SJ, Becker LE, Farley I, Shannak K. Brain neurotransmitters in dystonia musculorum deformans. N Eng] J Med 1986;315:347-353.
50. Black KJ, Ongur D, Perlmutter JS. Putamen volume in idiopathic focal dystonia. Neurology 1998;51:819-824.
51. Ozelius LJ, Hewett JW, Page CE, Bressman SB, Kramer PL, Shalish C, de Leon D, Brin MF, Raymond D, Corey DP, Fahn S, Risch NJ, Buckler AJ, Gusella JF, Breakefield XO. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 1997;17:40-48.
52. Graybiel AM, Ragsdale CW, Jr. Histochemically distinct compartments in the striatum of human, monkey, and cat demonstrated by acetylthiocholinesterase staining. Proc Natl Acad Sci U S A 1978; 75:5723-5726.
53. Gerfen CR, Baimbridge KG, Miller JJ. The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey. Proc Natl Acad Sci U S A 1985;82:8780-8784.
54. Reiner A, Albin RL, Anderson KD, D'Amato CJ, Penney JB, Young AB. Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A 1988;85:5733-5737.
55. Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997;12:133-147.
56. Hardie RJ, Pullon HW, Harding AE, Owen JS, Pires M, Daniels GL, Imai Y, Misra VP, King RH, Jacobs JM. Neuroacanthocytosis. A clinical, haematological and pathological study of 19 cases. Brain 1991;114:13-49.
57. Rajput AH, Gibb WR, Zhong XH, Shannak KS, Kish S, Chang LG, Hornykiewicz O. Dopa-responsive dystonia: pathological and biochemical observations in a case [see comments]. Ann Neurol 1994;35:396-402.
58. Furukawa Y, Nygaard TG, Gütlich M, Rajput AH, Pifl C, DiStefano L, Chang LJ, Price K, Shimadzu M, Hornykiewicz O, Haycock JW, Kish SJ. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia. Neurology 1999;53: 1032-1041.
59. Tabaddor K, Wolfson LI, Sharpless NS. Diminished ventricular fluid dopamine metabolites in adult-onset dystonia. Neurology 1978;28:1254-1258.
60. Wolfson LI, Sharpless NS, Thal LJ, Waltz JM, Shapiro K. Decreased ventricular fluid norepinephrine metabolite in childhood-onset dystonia. Neurology 1983;33:369-372.
61. Curzon G. Involuntary movements other than Parkinsonism: biochemical aspects. Proc R Soc Med 1973;66:873-876.
62. Goldman JE, Katz D, Rapin I, Purpura DP, Suzuki K. Chronic GM1 gangliosidosis presenting as dystonia: I.Clinical and pathological fetures. Ann Neurol 1981;9:465-475.
63. Yoshida K, Ikeda S, Kawaguchi K, Yanagisawa N. Adult GM1 gangliosidosis: immunohistochemical and ultrastructural findings in an autopsy case. Neurology 1994;44:2376-2382.
64. Uyama E, Terasaki T, Watanabe S, Naito M, Owada M, Araki S, Ando M. Type-3 GM1 gangliosidosis-characteristic MRI findings correlated with dystonia. Acta Neurol Scand 1992;86:609-615.
65. Hardie RJ, Young EP, Morgan-Hughes JA. Hexosaminidase A deficiency presenting as juvenile progressive dystonia [letter]. J Neurol Neurosurg Psychiatry 1988;51:446-447.
66. Meek D, Wolfe LS, Andermann E, Andermann F. Juvenile progressive dystonia: a new phenotype of GM2 gangliosidosis. Ann Neurol 1984;15:348-352.
67. Nardocci N, Bertagnolio B, Rumi V, Angelini L. Progressive dystonia symptomatic of juvenile GM2 gangliosidosis. Mov Disord 1992;7:64-67.
68. Turpin JC, Masson M, Baumann N. Clinical aspects of NiemannPick type C disease in the adult. Dev Neurosci 1991;13:304-306.
69. Marsden CD, Lang AE, Quinn NP, McDonald WI, Abdallat A, Nimri S. Familial dystonia and visual failure with striatal CT lucencies. J Neurol Neurosurg Psychiatry 1986;49:500-509.
70. Bruyn GW, Vielvoye GJ, Went LN. Hereditary spastic dystonia: a new mitochondrial encephalopathy? Putaminal necrosis as a diagnostic sign. J Neurol Sci 1991;103:195-202.
71. Berkovic SF, Karpati G, Carpenter S, Lang AE. Progressive dystonia with bilateral putaminal hypodensities. Arch Neurol 1987; 44:1184-1187.
72. Caparros-Lefebvre D, Destee A, Petit H. Late onset familial dystonia: could mitochondrial deficits induce a diffuse lesioning process of the whole basal ganglia system? J Neurol Neurosurg Psychiatry 1997;63:196-203.
73. He F, Zhang S, Qian F, Zhang C. Delayed dystonia with striatal CT lucencies induced by a mycotoxin (3-nitropropionic acid). Neurology 1995;45:2178-2183.
74. Palfi S, Ferrante RJ, Brouillet E, Beal MF, Dolan R, Guyot MC, Peschanski M, Hantraye P. Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of huntington's disease. J Neurosci 1996;16:3019-3025.
75. Roig M, Calopa M, Rovira A, Macaya A, Riudor E, Losada M. Bilateral striatal lesions in childhood. Pediat Neurol 1993;9:349-358.
76. Shimoizumi H, Okabe I, Kodama H, Yanagisawa M. Methylmalonic acidemia with bilateral MRI high intensities of the globus pallidus. No To Hattatsu 1993;25:554-557.
77. Stromme P, Stokke O, Jellum E, Skjeldal OH, Baumgartner R. Atypical methylmalonic aciduria with progressive encephalopathy, microcephaly and cataract in two siblings-a new recessive syndrome? Clin Genet 1995;48:1-5.
78. Davous P, Rondot P. Homocystinuria and dystonia. J Neurol Neurosurg Psychiatry 1983;46:283-286.
79. Hagberg B, Hambraeus L, Bensch K. A case of homocystinuria with a dystonia neurological syndrome. Neuropadiatrie 1970;1: 337-343.
80. Kempster PA, Brenton DP, Gale AN, Stern GM. Dystonia in homocystinuria. J Neurol Neurosurg Psychiatry 1988;51:859-862.
81. Berardelli A, Thompson PD, Zaccagnini M, Giardini O, D'Eufemia P, Massoud R, Manfredi M. Two sisters with generalized dystonia associated with homocystinuria. Mov Disord 1991; 6:163-165.
82. Darras BT, Gilmore HE. Focal intermittent dystonia in Hartnup disease. Ann Neurol 1985;18:397-398.
83. Schmidtke K, Endres W, Roscher A, Ibel H, Herschkowitz N, Bachmann C, Plochl E, Hadorn HB. Hartnup syndrome, progressive encephalopathy and allo-albuminaemia. A clinicopathological case study. Eur J Pediatr 1992;151:899-903.
84. Bergman I, Finegold D, Gartner JC, Jr, Zitelli BJ, Claassen D, Scarano J, Roe CR, Stanley C, Goodman SI. Acute profound dystonia in infants with glutaric acidemia. Pediatrics 1989;83:228-234.
85. Leibel RL, Shih VE, Goodman SI, Bauman ML, McCabe ER, Zwerdling RG, Bergman I, Costello C. Glutaric acidemia: a metabolic disorder causing progressive choreoathetosis. Neurology 1980;30:1163-1168.
86. Amir N, el Peleg O, Shalev RS, Christensen E. Glutaric aciduria type I: clinical heterogeneity and neuroradiologic features [see comments]. Neurology 1987;37:1654-1657.
87. Kyllerman M, Skjeldal OH, Lundberg M, Holme I, Jellum E, von Dobeln U, Fossen A, Carlsson G. Dystonia and dyskinesia in glutaric aciduria type I: clinical heterogeneity and therapeutic considerations. Mov Disord 1994;9:22-30.
88. Goodman SI, Norenberg MD, Shikes RH, Breslich DJ, Moe PG. Glutaric aciduria: biochemical and morphologic considerations. J Pediatr 1977;90:746-750.
89. Pfluger T, Weil S, Muntau A, Willemsen UF, Hahn K. Glutaric aciduria type I: a serious pitfall if diagnosed too late. Eur Radiol 1997;7:1264-1266.
90. Rivinus TM, Jamison DL, Graham PJ. Childhood organic neurological disease presenting as psychiatric disorder. Arch Dis Child 1975;50:115-119.
91. Yatziv S, Russell A. An unusual form of metachromatic leukodystrophy in three siblings. Clin Genet 1981;19:222-227.
92. Ozand PT, Gascon GG, Al Essa M, Joshi S, Al Jishi E, Bakheet S, Al Watban J, al Kawi MZ, Dabbagh O. Biotin-responsive basal ganglia disease: a novel entity. Brain 1998;121:1267-1279.